<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>FTD on Agnès Pérez-Millan</title>
    <link>https://Agnes2.github.io/tags/ftd/</link>
    <description>Recent content in FTD on Agnès Pérez-Millan</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 27 Dec 2023 00:00:00 +0000</lastBuildDate><atom:link href="https://Agnes2.github.io/tags/ftd/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Impact of demographics and comorbid conditions on plasma biomarkers concentrations and their diagnostic accuracy in a memory clinic cohort</title>
      <link>https://Agnes2.github.io/publications/2023-plasma/</link>
      <pubDate>Wed, 27 Dec 2023 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2023-plasma/</guid>
      <description>Jordi Sarto, Diana Esteller-Gauxax, Adrià Tort-Merino, Núria Guillén, Agnès Pérez‐Millan, Neus Falgàs, Sergi Borrego-Écija, Guadalupe Fernández-Villullas, Beatriz Bosch, Jordi Juncà-Parella, Anna Antonell, Laura Naranjo, Raquel Ruiz-García, Josep María Augé, Raquel Sánchez-Valle, Albert Lladó, Mircea Balasa. Journal of Neurology.
ABSTRACT
Plasma biomarkers have emerged as promising tools for identifying amyloid beta (Aβ) pathology. Before implementation in routine clinical practice, confounding factors modifying their concentration beyond neurodegenerative diseases should be identified. We studied the association of a comprehensive list of demographics, comorbidities, medication and laboratory parameters with plasma p-tau181, glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) on a prospective memory clinic cohort and studied their impact on diagnostic accuracy for discriminating CSF/amyloid PET-defined Aβ status.</description>
    </item>
    
    <item>
      <title>Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity</title>
      <link>https://Agnes2.github.io/publications/2023-gal3/</link>
      <pubDate>Wed, 29 Nov 2023 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2023-gal3/</guid>
      <description>Sergi Borrego-Écija*, Agnès Pérez-Millan*, Anna Antonell, Laura Fort-Aznar, Elif Kaya-Tilki, Alberto León-Halcón, Albert Lladó, Laura Molina-Porcel, Mircea Balasa, Jordi Juncà-Parella, Javier Vitorica, Jose Luis Venero, Tomas Deierborg, Antonio Boza-Serrano, Raquel Sánchez-Valle. (* equivalent contribution). Alzheimer&amp;rsquo;s &amp;amp; Dementia.
ABSTRACT
INTRODUCTION Neuroinflammation is a major contributor to the progression of frontotemporal dementia (FTD). Galectin-3 (Gal-3), a microglial activation regulator, holds promise as a therapeutic target and potential biomarker. Our study aimed to investigate Gal-3 levels in patients with FTD and assess its diagnostic potential.</description>
    </item>
    
    <item>
      <title>Cortical thickness modeling and variability in Alzheimer’s disease and frontotemporal dementia</title>
      <link>https://Agnes2.github.io/publications/2023-cth/</link>
      <pubDate>Mon, 27 Nov 2023 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2023-cth/</guid>
      <description>Agnès Pérez‐Millan, Sergi Borrego-Écija, Neus Falgàs, Jordi Juncà-Parella, Beatriz Bosch, Adrià Tort-Merino, Anna Antonell, Nuria Bargalló, Lorena Rami, Mircea Balasa, Albert Lladó, Roser Sala-Llonch, Raquel Sánchez-Valle. Journal of Neurology.
ABSTRACT
Background and objective Alzheimer’s disease (AD) and frontotemporal dementia (FTD) show different patterns of cortical thickness (CTh) loss compared with healthy controls (HC), even though there is relevant heterogeneity between individuals suffering from each of these diseases. Thus, we developed CTh models to study individual variability in AD, FTD, and HC.</description>
    </item>
    
    <item>
      <title>OHBM 2023 ANNUAL MEETING</title>
      <link>https://Agnes2.github.io/conferences/2023-ohbm/</link>
      <pubDate>Sat, 22 Jul 2023 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/conferences/2023-ohbm/</guid>
      <description>MERIT POSTER AWARD
AUTHORS: Agnès Pérez-Millan, Bertrand Thirion, Sergi Borrego‐Écija, José Contador, Jordi Juncà-Parella, Beatriz Bosch, Neus Falgàs, Anna Antonell, Mircea Balasa, Albert Lladó, Raquel Sanchez-Valle, Roser Sala-Llonch.
TITLE: Probabilistic classification of Alzheimer’s Disease and Frontotemporal Dementia.
CONFERENCE: OHBM 2023 ANNUAL MEETING
PLACE: Montréal, Canada
DATES: July 22 - 26, 2023</description>
    </item>
    
    <item>
      <title>AAIC 2023</title>
      <link>https://Agnes2.github.io/conferences/2023-aaicml/</link>
      <pubDate>Sun, 16 Jul 2023 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/conferences/2023-aaicml/</guid>
      <description>AUTHORS: Agnès Pérez-Millan, Bertrand Thirion, Sergi Borrego‐Écija, José Contador, Jordi Juncà-Parella, Beatriz Bosch, Neus Falgàs, Anna Antonell, Raquel Ruiz-García, Laura Naranjo, Mircea Balasa, Albert Lladó,Roser Sala-Llonch, Raquel Sanchez-Valle.
TITLE: Probabilistic computer-aided diagnosis of Alzheimer’s disease and frontotemporal dementia based on MRI and biochemical markers.
CONFERENCE: Alzheimer’s Association International Conference (AAIC) 2023
PLACE: Amsterdam, Netherlands
DATES: July 16 - 20, 2023</description>
    </item>
    
    <item>
      <title>AAIC 2023</title>
      <link>https://Agnes2.github.io/conferences/2023-aaicsb/</link>
      <pubDate>Sun, 16 Jul 2023 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/conferences/2023-aaicsb/</guid>
      <description>AUTHORS: Sergi Borrego Écija, Jordi Juncà-Parella, Raquel Ruiz-García, Jordi Sarto, Neus Falgàs, Diana Esteller, Núria Guillén, Agnès Pérez-Millan, Guadalupe Fernández, Yolanda González, Adrià Tort-Merino, Bea Bosch, Laura Fort-Aznar, Anna Antonell, Laura Naranjo, Albert Lladó, Mircea Balasa, Raquel Sanchez-Valle.
TITLE: Plasma Nfl predicts neuroimaging alterations and functional decline in frontotemporal dementia.
CONFERENCE: Alzheimer’s Association International Conference (AAIC) 2023
PLACE: Amsterdam, Netherlands
DATES: July 16 - 20, 2023</description>
    </item>
    
    <item>
      <title>Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study</title>
      <link>https://Agnes2.github.io/publications/2022-c9/</link>
      <pubDate>Wed, 01 Mar 2023 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2022-c9/</guid>
      <description>Agnès Pérez-Millan*, Sergi Borrego-Écija*, John C van Swieten, Lize Jiskoot, Fermin Moreno, Robert Laforce, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik Vandenberghe, Alexandre de Mendonça, Chris R Butler, Alexander Gerhard, Simon Ducharme, Isabelle Le Ber, Isabel Santana, Florence Pasquier, Johannes Levin, Markus Otto, Sandro Sorbi, Pietro Tiraboschi, Harro Seelaar, Tobias Langheinrich, Jonathan D Rohrer, Roser Sala-Llonch, Raquel Sánchez-Valle &amp;amp; The Genetic FTD Initiative, GENFI (* equivalent contribution).</description>
    </item>
    
    <item>
      <title>Classifying Alzheimer’s disease and frontotemporal dementia using machine learning with cross‐sectional and longitudinal magnetic resonance imaging data</title>
      <link>https://Agnes2.github.io/publications/2023-mllong/</link>
      <pubDate>Wed, 04 Jan 2023 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2023-mllong/</guid>
      <description>Agnès Pérez‐Millan, José Contador, Jordi Juncà‐Parella, Beatriz Bosch, Laia Borrell, Adrià Tort‐Merino, Neus Falgàs, Sergi Borrego‐Écija, Nuria Bargalló, Lorena Rami, Mircea Balasa, Albert Lladó, Raquel Sánchez‐Valle, Roser Sala‐Llonch. Human Brain Mapping.
ABSTRACT
Alzheimer&amp;rsquo;s disease (AD) and frontotemporal dementia (FTD) are common causes of dementia with partly overlapping, symptoms and brain signatures. There is a need to establish an accurate diagnosis and to obtain markers for disease tracking. We combined unsupervised and supervised machine learning to discriminate between AD and FTD using brain magnetic resonance imaging (MRI).</description>
    </item>
    
    <item>
      <title>33rd International Symposium on ALS/MND</title>
      <link>https://Agnes2.github.io/conferences/2022-alsmnd/</link>
      <pubDate>Tue, 06 Dec 2022 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/conferences/2022-alsmnd/</guid>
      <description>AUTHORS: Sergi Borrego-Écija, Agnès Pérez-Millan, John C van Swieten, Lize Jiskoot, Fermin Moreno, Robert Laforce, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik Vandenberghe, Alexandre de Mendonça, Chris R Butler, Alexander Gerhard, Simon Ducharme, Isabelle Le Ber, Isabel Santana, Florence Pasquier, Johannes Levin, Markus Otto, Sandro Sorbi, Pietro Tiraboschi, Harro Seelaar, Tobias Langheinrich, Jonathan D Rohrer, Roser Sala-Llonch, Raquel Sánchez-Valle &amp;amp; The Genetic FTD Initiative, GENFI.</description>
    </item>
    
    <item>
      <title>Classification between early onset Alzheimer´s disease and frontotemporal dementia using a single neuroimaging feature</title>
      <link>https://Agnes2.github.io/publications/2022-etaiml/</link>
      <pubDate>Mon, 03 Oct 2022 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2022-etaiml/</guid>
      <description>Agnès Pérez Millan, Laia Borrell, José Contador, Mircea Balasa, Albert Lladó, Raquel Sanchez-Valle, Roser Sala-Llonch. Emerging Topics in Artificial Intelligence (ETAI) 2022.
ABSTRACT
INTRODUCTION: Early Onset Alzheimer’s Disease (EOAD, &amp;lt;65 years) and Frontotemporal Dementia (FTD) are common forms of early-onset dementia. Therefore, there is a need to establish accurate diagnosis and to obtain markers for disease tracking. We combined supervised and unsupervised machine learning (ML) to discriminate between EOAD and FTD patients.</description>
    </item>
    
    <item>
      <title>Differential Gene Expression in Sporadic and Genetic Forms of Alzheimer’s Disease and Frontotemporal Dementia in Brain Tissue and Lymphoblastoid Cell Lines</title>
      <link>https://Agnes2.github.io/publications/2022-gens/</link>
      <pubDate>Sat, 01 Oct 2022 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2022-gens/</guid>
      <description>Oscar Ramos-Campoy, Albert Lladó, Beatriz Bosch, Mireia Ferrer, Agnès Pérez-Millan, Miguel Vergara, Laura Molina-Porcel, Laura Fort-Aznar, Ricardo Gonzalo, Fermín Moreno-Izco, Guadalupe Fernandez-Villullas, Mircea Balasa, Raquel Sánchez-Valle, Anna Antonell. Molecular Neurobiology.
ABSTRACT
Sporadic early-onset Alzheimer’s disease (EOAD) and autosomal dominant Alzheimer’s disease (ADAD) provide the opportunity to investigate the physiopathological mechanisms in the absence of aging, present in late-onset forms. Frontotemporal dementia (FTD) causes early-onset dementia associated to tau or TDP43 protein deposits.</description>
    </item>
    
    <item>
      <title>Emerging Topics in Artificial Intelligence (ETAI) 2022</title>
      <link>https://Agnes2.github.io/conferences/2022-etai/</link>
      <pubDate>Wed, 24 Aug 2022 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/conferences/2022-etai/</guid>
      <description>AUTHORS: Agnès Pérez-Millan, Laia Borrell,José Contador,Mircea Balasa, Albert Lladó, Raquel Sanchez-Valle, Roser Sala-Llonch.
TITLE: Classification between Early Onset Alzheimer&amp;rsquo;s disease and frontotemporal dementia using a single neuroimaging feature.
CONFERENCE: Emerging Topics in Artificial Intelligence (ETAI) 2022
PLACE: San Diego, Unitated States of America
DATES: August 21 - 25, 2022
ABSTRACT:
INTRODUCTION: Early Onset Alzheimer’s Disease (EOAD) and Frontotemporal Dementia (FTD) are common forms of early-onset dementia. Therefore, there is a need to establish accurate diagnosis and to obtain markers for disease tracking.</description>
    </item>
    
    <item>
      <title>OHBM 2022 ANNUAL MEETING</title>
      <link>https://Agnes2.github.io/conferences/2022-ohbmapm/</link>
      <pubDate>Wed, 22 Jun 2022 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/conferences/2022-ohbmapm/</guid>
      <description>AUTHORS: Agnès Pérez-Millan, José Contador, Neus Falgàs, Núria Bargalló, Mircea Balasa, Albert Lladó, Raquel Sanchez-Valle, Roser Sala-Llonch.
TITLE: Prognosis of Alzheimer’s Disease and Frontotemporal Dementia with a brain age model.
CONFERENCE: OHBM 2022 ANNUAL MEETING
PLACE: Glasgow, United Kingdom
DATES: June 19 - 23, 2022
ABSTRACT:
Introduction: Alzheimer Disease (AD) and Frontotemporal Dementia (FTD) are common forms of dementia, characterized by progressive brain atrophy at variable rates along the age continuum.</description>
    </item>
    
    <item>
      <title>OHBM 2022 ANNUAL MEETING</title>
      <link>https://Agnes2.github.io/conferences/2022-ohbmut/</link>
      <pubDate>Tue, 21 Jun 2022 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/conferences/2022-ohbmut/</guid>
      <description>AUTHORS: Uma Maria Lal-Trehan Estrada, Agnès Pérez-Millan, José Contador, Neus Falgàs, Núria Bargalló, Mircea Balasa, Albert Lladó, Raquel Sanchez-Valle, Roser Sala-Llonch.
TITLE: Indices of cortical asymmetry in Alzheimer’s Disease and Frontotemporal Dementia.
CONFERENCE: OHBM 2022 ANNUAL MEETING
PLACE: Glasgow, United Kingdom
DATES: June 19 - 23, 2022
ABSTRACT:</description>
    </item>
    
    <item>
      <title>AD/PD 2022 International Conference on Alzheimer’s and Parkinson’s Diseases</title>
      <link>https://Agnes2.github.io/conferences/2022-adpd/</link>
      <pubDate>Wed, 16 Mar 2022 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/conferences/2022-adpd/</guid>
      <description>AUTHORS: Agnès Pérez-Millan, José Contador, Neus Falgàs, Núria Bargalló, Mircea Balasa, Albert Lladó, Raquel Sanchez- Valle, Roser Sala-Llonch
TITLE: Using age-matched templates to depict patterns of atrophy in AD and FTD.
CONFERENCE: AD/PD 2022 International Conference on Alzheimer’s and Parkinson’s Diseases
PLACE: Barcelona, Spain
DATES: March 15 - 20, 2022
ABSTRACT:
OBJECTIVES: Alzheimer Disease (AD) and Frontotemporal Dementia (FTD) are characterized by progressive brain atrophy at variable rates along the age continuum.</description>
    </item>
    
    <item>
      <title>Jornada STEM: visibilitzem l’enginyeria</title>
      <link>https://Agnes2.github.io/conferences/2022-youngitgirls/</link>
      <pubDate>Tue, 01 Feb 2022 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/conferences/2022-youngitgirls/</guid>
      <description>AUTHORS: Agnès Pérez-Millan, Laia Borrell, José Contador, Mircea Balasa, Albert Lladó, Raquel Sanchez-Valle, Roser Sala-Llonch.
TITLE: Classificació entre la malaltia d’Alzheimer i la demència frontotemporal mitjançant una única característica de neuroimatge.
CONFERENCE: Jornada STEM: visibilitzem l’enginyeria
PLACE: Barcelona, Spain
DATES: February 1, 2022</description>
    </item>
    
    <item>
      <title>2021 Annual Meeting of the ISMRM Iberian Chapter</title>
      <link>https://Agnes2.github.io/conferences/2021-isrm/</link>
      <pubDate>Thu, 17 Jun 2021 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/conferences/2021-isrm/</guid>
      <description>AUTHORS: Agnès Pérez-Millan, Laia Borrell, José Contador, Mircea Balasa, Albert Lladó, Raquel Sanchez-Valle, Roser Sala-Llonch.
TITLE: Classification between Alzheimer’s disease and frontotemporal dementia using a single neuroimaging feature.
CONFERENCE: 2021 Annual Meeting of the ISMRM Iberian Chapter
PLACE: Virtual Event
DATES: June 16 - 17, 2021
ABSTRACT:
INTRODUCTION: Alzheimer Disease (AD) and Frontotemporal Dementia (FTD) are common forms of early-onset dementia with different, but partly overlapping, symptoms and brain signatures. There is a need to establish accurate diagnosis and to obtain good markers for prognosis.</description>
    </item>
    
    <item>
      <title>Contribution of CSF biomarkers to early-onset Alzheimer’s disease and frontotemporal dementia neuroimaging signatures</title>
      <link>https://Agnes2.github.io/publications/2020-ohbm/</link>
      <pubDate>Mon, 06 Jan 2020 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2020-ohbm/</guid>
      <description>Neus Falgàs, Mariona Ruiz‐Peris, Agnès Pérez‐Millan, Roser Sala‐Llonch, Anna Antonell, Mircea Balasa, Sergi Borrego‐Écija, Oscar Ramos‐Campoy, Josep Maria Augé, Magdalena Castellví, Adrià Tort‐Merino, Jaume Olives, Guadalupe Fernández‐Villullas, Kaj Blennow, Henrik Zetterberg, Núria Bargalló, Albert Lladó, Raquel Sánchez‐Valle. Human Brain Mapping.
ABSTRACT
Prior studies have described distinct patterns of brain gray matter and white matter alterations in Alzheimer&amp;rsquo;s disease (AD) and frontotemporal lobar degeneration (FTLD), as well as differences in their cerebrospinal fluid (CSF) biomarkers profiles.</description>
    </item>
    
  </channel>
</rss>
